|
[µ¥Àϸ®¸Þµð °íÀç¿ì ±âÀÚ] ÇѾç´ëº´¿øÀº 10¿ù6ÀÏ Àǰú´ëÇÐ º»°ü 6Ãþ TBL½Ç¿¡¼ 'Á¦5ȸ ¾Ï¼¾ÅÍ ½ÉÆ÷Áö¾ö'À» °³ÃÖÇÑ´Ù°í 30ÀÏ ¹àÇû´Ù.
½ÉÆ÷Áö¾öÀº ÃÑ3°³ÀÇ ¼¼¼ÇÀ¸·Î ±¸¼ºµÆ´Ù. ù ¹øÂ° ¼¼¼ÇÀº ÇѾç´ëº´¿ø ±Ç¼ºÁØ ±³¼ö(¿Ü°ú)¿Í ±èµ¿¼± ±³¼ö(³»ºÐºñ´ë»ç³»°ú)°¡ ÁÂÀåÀ» ¸Ã°í, ¼Û¿µ¼ö ±³¼ö(º´¸®°ú)°¡ ‘Bioinfomatics & NGS’, ±è¿©Àº ±³¼ö(Áø´Ü°Ë»çÀÇÇаú°¡ ‘Hereditary cancer syndrome’. ½Å¼öÁø º´¸®°ú ±³¼ö°¡ ‘Clinical application of NGS’ µîÀ» ÁÖÁ¦·Î °¿¬ÇÑ´Ù.
µÎ ¹øÂ° ¼¼¼ÇÀº Á¤¿ø»ó ±³¼ö(ÈäºÎ¿Ü°ú)¿Í ÀÌ¿µÈ£ ±³¼ö(¼Ò¾ÆÃ»¼Ò³â°ú)°¡ ÁÂÀåÀ» ¸Ã°í, ¹éÁ¤Èì °¡Ãµ´ë ±æº´¿ø ±³¼ö°¡ ‘MDT with Watson for Oncology in Solid Tumor’, ¾çÇöÁø ¹Ú»ç(¢ß½ÅÅ×Ä«¹ÙÀÌ¿À)°¡ ‘Leveraging genomic data and AI in precision medicine’, ÀÌÀ¯¶ó ¼¿ï¾Æ»êº´¿ø ±³¼ö°¡ ‘Information technology for predictive, preventive, personalized and participatory medicine’ µîÀ» ÁÖÁ¦·Î ¹ßÇ¥ÇÑ´Ù.
¼¼ ¹øÂ° ¼¼¼Ç¿¡¼´Â ÃÖÈ£¼ø ±³¼ö(¼Òȱ⳻°ú)°¡ ÁÂÀåÀ» ¸Ã°í, À±ÀçÈÆ ±³¼ö(¼Òȱ⳻°ú)°¡ ‘chemotherapy’, ¹ÚÇýÁø ±³¼ö(¹æ»ç¼±Á¾¾çÇаú)°¡ ‘Radiotherapy’ µî¿¡ ´ëÇØ °¿¬À» ÆîÄ£´Ù. |